Compare NUVB & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | AKR |
|---|---|---|
| Founded | 2018 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | N/A | 1993 |
| Metric | NUVB | AKR |
|---|---|---|
| Price | $8.98 | $20.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $10.63 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 6.1M | 1.3M |
| Earning Date | 11-03-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 3.85% |
| EPS Growth | N/A | ★ 18.54 |
| EPS | N/A | ★ 0.12 |
| Revenue | $26,748,000.00 | ★ $389,489,000.00 |
| Revenue This Year | $609.55 | N/A |
| Revenue Next Year | $197.91 | $16.18 |
| P/E Ratio | ★ N/A | $168.47 |
| Revenue Growth | ★ 1137.19 | 6.01 |
| 52 Week Low | $1.54 | $16.98 |
| 52 Week High | $9.75 | $24.95 |
| Indicator | NUVB | AKR |
|---|---|---|
| Relative Strength Index (RSI) | 61.71 | 54.39 |
| Support Level | $8.84 | $20.11 |
| Resistance Level | $9.75 | $21.17 |
| Average True Range (ATR) | 0.43 | 0.42 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 56.50 | 55.40 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.